Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-10 @ 11:18 PM
Study NCT ID:
NCT03450967
Status:
UNKNOWN
Last Update Posted:
2021-08-10
First Post:
2018-02-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab Plus Tremelimumab Combined With Proton Therapy for HNSCC
Sponsor:
Samsung Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Head and Neck Squamous Cell Carcinoma | View |
Keywords: